WAY 100635(CAS: 146714-97-8)

WAY 100635 (CAS: 146714-97-8) is subject to various regulations including the REACH regulations in the European Union, which require registration, evaluation, authorization, and restriction of chemicals. Additionally, it may fall under the U.S. EPA's TSCA (Toxic Substances Control Act) and the FDA's regulations for pharmaceuticals. It is important to comply with GHS (Globally Harmonized System of Classification and Labeling of Chemicals) guidelines for proper labeling and handling.

Alternatives to WAY 100635 (CAS: 146714-97-8) in synthesis might include other selective PDE4 inhibitors. Isomers and analogs of WAY 100635, such as ARL 67152, could be considered. These alternatives offer similar pharmacological profiles but with potential differences in efficacy and toxicity, making them viable options depending on the specific application.

The market for WAY 100635 (CAS: 146714-97-8) is primarily driven by its use as a research tool in the study of inflammatory and neurodegenerative diseases. Research trends indicate growing interest in its potential therapeutic applications, particularly in treating conditions such as multiple sclerosis and asthma. The demand for WAY 100635 is expected to increase with ongoing clinical studies and advancements in understanding its pharmacological properties.

Waste containing WAY 100635 (CAS: 146714-97-8) should be collected in appropriate containers and stored in a secure, dry location. It is crucial to handle the waste according to local and international regulations, such as the REACH regulations in the EU. Proper incineration or professional waste disposal services should be utilized. Environmental protection precautions must be taken to prevent accidental exposure or contamination. Always consult the safety data sheet (SDS) for specific disposal guidelines.